期刊文献+

2型糖尿病合并不同分期慢性肾脏疾病患者的血压特点

Characteristics of blood pressure in type 2 diabetic patients with different degree of chronic kidney disease
原文传递
导出
摘要 目的 观察2型糖尿病合并不同分期慢性肾脏疾病(CKD)患者的血压特点.方法 将2型糖尿病合并CKD患者共409例,分为CKD1期组(127例)、CKD2期组(121例)、CKD3期组(81例)、CKD4期组(36例)、CKD5期组(44例),统计各组高血压发生率,比较各组血压水平、节律特点.结果 随CKD进展,2型糖尿病合并CKD患者高血压发生率逐渐增加(x2=28.363,P<0.05),单纯收缩期高血压比例逐渐升高(x2=15.324,P<0.05),脉压水平逐渐升高(F=16.229,P<0.05);血压节律方面,随CKD进展,夜间血压下降百分率逐渐降低(F=6.753,5.105,P均<0.05),非杓型血压所占比例逐渐上升(x2=26.980,P<0.05).结论 2型糖尿病患者合并CKD分期不同,血压异常改变特点不同,整体血压异常特点为收缩压升高为主,脉压增大,同时伴血压节律异常. Objective To investigate the characteristics of blood pressure in type 2 diabetic patients with different degree of chronic kidney disease(CKD).Methods Four hundred and nine patients of type 2 diabetes with CKD were divided into 5 groups:stage 1 group(n =127),stage 2 group(n =121),stage 3 group (n=81),stage 4 group (n=36) and stage 5 group (n=44).The incidence of hypertension,variability of blood pressure and circadian rhythm were evaluated.Results In type 2 diabetic patients with CKD,the incidence of hypertension,proportion of isolated systolic hypertension and level of pulse pressure increased significantly with the progression of CKD (x2=28.363,15.324,F =16.229,all P 〈 0.05).And with the progression of CKD,the declining percentage of nocturnal blood pressure decreased (F =6.753,5.105,all P〈 0.05),while the percentage of non-dippers increased(x2=26.980,P 〈0.05).Conclusion The abnormality of blood pressure in type 2 diabetes is diverse at different stage of CKD,however increased systolic blood pressure and pulse pressure and abnormal circadian rhythm are common characters.
出处 《国际内分泌代谢杂志》 2015年第3期149-152,共4页 International Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目(81173428,81373864)
关键词 糖尿病 慢性肾脏疾病 高血压 昼夜节律 Diabetes mellitus Chronic kidney disease Hypertension Circadian rhythm
  • 相关文献

参考文献15

  • 1Centers for Disease Control and Prevention (CDC).Prevalence of chronic kidney disease and associated risk factors-United States, 1999-2004[J].MMWR Morb Mortal Wkly Rep,2007,56 (8) : 161-165.
  • 2Levey,AS,Coresh J,Balk E,et al.National Kidney Foundation practice guidelines for chronic kidney disease:evaluation, classification,and stratification [J].Ann Intern Med, 2003,139( 2 ) : 137-147.
  • 3Anantharaman R,Bhansali A,Bhadada SK,et al.A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy[J].Indian J Med Res, 2011,134(5 ) : 658-663.
  • 4Laurent S,Schlaich M,Esler M.New drugs,procedures,and devices for hypertension[J].Lancet, 2012,380(9841 ) : 591-600.
  • 5Chobanian AV, Bakris GL, Black HR, et al.Seventh report of the Joint National Committee on Prevention,Detection,Evaluation, and Treatment of High Blood Pressure[J].Hypertension,2003,42 (6), 1206-1252.
  • 6中华医学会糖尿病学分会慢性并发症调查组.1991~2000年全国住院糖尿病患者慢性并发症及相关大血管病变回顾性分析[J].中国医学科学院学报,2002,24(5):447-451. 被引量:264
  • 7林静,丁小强,吉俊,傅辰生,钟一红,邹建州,滕杰,方艺.慢性肾脏病患者高血压现状的横断面调查[J].中华肾脏病杂志,2009,25(11):827-831. 被引量:35
  • 8Retnakaran R, Cull CA, Thome KI, et al. Risk factors for renal dysfunction in type 2 diabetes:U.K. Prospective Diabetes Study 74[J].Diabetes,2006,55(6) : 1832-1839.
  • 9Pedrinelli R,Dell'omo G,Penno G,et al.Microalbuminuria and pulse pressure in hypertensive and atherosclemtic men [J]. Hypertension, 2000,35 ( 1 Ptl ):48-54.
  • 10van den Hurk K,Magliano DJ,Alssema M,et al.Type 2 diabetes strengthens the association between pulse pressure and chronic kidney disease : the AusDiab study[J].J Hypertens, 2011,29(5 ) : 953-960.

二级参考文献38

  • 1猿田享男,任常陵.日本高血压学会高血压治疗指南及其特征(2004年修订版)[J].日本医学介绍,2006,27(5):198-200. 被引量:2
  • 2全国糖尿病研究协作组调查研究组.全国14省市30万人口中糖尿病调查报告[J].中华内科杂志,1981,20(11):678-678.
  • 3Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-200,4. Hypertension, 2007, 49: 69-75.
  • 4Centers for Disease Control and Prevention(CDC). Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004. MMWR Morb Mortal Wkly Rep, 2007, 56: 161-165.
  • 5Sarafidis PA, Ei S, Chen SC, et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med, 2008, 121: 332-340.
  • 6Jafar TH, Schmid CH, Landa M, et al. Angiotensinconverting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med, 2001, 135: 73-87.
  • 7K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis, 2004, 43(5 Suppl 1): S1-S290.
  • 8Lenfant C, Chobanian AV, Jones DW, et al. Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension, 2003, 41: 1178-1179.
  • 9Whitworth JA. 2003 World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens, 2003, 21: 1983- 1992.
  • 10Churg J BJ, Glassock RJ. Renal disease: classification and atlas of glomerular diseases. 2nd ed. Tokyo: lgaku-Shoin, 1995: 1-225.

共引文献317

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部